To further study the mechanism of hormone dependent induction of CLEC10A ligands, we treated MCF7 and T47D breast cancer cells as well as the ER−/PR-negative breast cancer cell line MDA-MB-231 with the estrogen receptor modulator 4-hydroxy-tamoxifen (Tam). This evidence concerns the gene ESR1 and breast carcinoma.